Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pricing Could Help Lundbeck's Vyepti In Slow-Growing CGRP Market
Feb 27 2020
•
By
Mandy Jackson
Vyepti is now approved in the US for migraine prevention • Source: Shutterstock
More from New Products
More from Scrip